MEDNAX Continues Its Expansion in Radiology with the Acquisition of Another Leading South Florida Radiology Practice
This marks the Company’s ninth radiology practice acquisition, further establishing MEDNAX Radiology Solutions as one of the largest radiology practices in the nation, reading more than 11.7 million studies through its more than 750 board-certified or eligible radiologists.
The practice specializes in vascular radiology, interventional
radiology, breast imaging, neuroradiology, diagnostic imaging and
nuclear medicine, and has provided services to Bethesda Hospital East
and Bethesda Hospital West for 45 years. In addition, the group services
the Bethesda Outpatient Imaging Center at Bethesda Health City and
“We are excited to join
This was a cash transaction and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.
With this acquisition, nine physician group practices have become part
of
ABOUT
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
View source version on businesswire.com: https://www.businesswire.com/news/home/20181126005066/en/
Source:
Charles Lynch
Vice President, Strategy and Investor Relations
954-384-0175
ext. 5692
charles_lynch@mednax.com